DENTSPLY SIRONA Inc.

XRAY · NasdaqGS · Stock · Healthcare
$8.44
-0.76% today
Delayed price,

What DENTSPLY SIRONA does

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$1.68B
P/E (ttm)
—
Forward P/E
5.6
Dividend yield
0.00%
Beta
0.88
Profit margin
-15.0%
Employees
14,000
Headquarters
Charlotte, NC, United States
Exchange
NasdaqGS

Performance

1 Month
-11.5%
3 Months
-39.9%
6 Months
-32.5%
1 Year
-32.5%
5 Years
-82.7%
$8.3352-week range$14.76
Biggest setback — last 12 months
-42.5%
23 Feb 2026 → 12 Oct 2026
Fell from $14.68 to $8.44 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+40.5%
1 Jun 2026 → 13 Jul 2026
Ran from $10.00 to $14.05 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▼ Trend: Downtrend
Price is below its 20-, 50- and 200-day averages, each stacked below the next — a classic technical downtrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$7.39 (-12.4%)$8.44$9.63 (+14.2%)
3 Months$6.71 (-20.5%)$8.44$10.62 (+25.8%)
6 Months$6.10 (-27.7%)$8.44$11.67 (+38.3%)
12 Months$5.34 (-36.8%)$8.44$13.35 (+58.2%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 45.9%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 3,323 shares at $9.03 — MAZELSKY JONATHAN JAY, Director · 2026-10-02
Acquired 24,014 shares — Fortson John C., EVP & CFO · 2026-08-12
Sold 802 shares at $12.12 — Frohning Andrea L., SVP, CHRO · 2026-08-11
Acquired 2,842 shares at $10.56 — MAZELSKY JONATHAN JAY, Director · 2026-07-01
Acquired 6,500 shares at $9.99 — HOSEIN CLYDE, Director · 2026-06-16
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.